# Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia

> **NCT02701374** · PHASE2 · COMPLETED · sponsor: **Toray Industries, Inc** · enrollment: 184 (actual)

## Conditions studied

- Post-Herpetic Neuralgia

## Interventions

- **DRUG:** TRK-700
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02701374
- **Lead sponsor:** Toray Industries, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2017-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02701374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02701374, "Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02701374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*